Fresenius Medical Care AG (FMCQF)
Fresenius Medical Care AG operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Bad Homburg, HE, DE. The stock last traded at $51.44, up 0.00% on the session, giving a market capitalisation of $13.81B. On trailing twelve-month figures it carries a trailing P/E of 12.35, a net margin of 4.8%. Its beta of 0.73 implies it has historically moved less than the broad market.
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG is most often compared with the following Healthcare names: